Research News | Research News – Research Information

psilocybin

08/27/2018 / By Isabelle Z.

Clinical trial using magic mushrooms to treat depression gets go-ahead from FDA

The FDA has just granted U.S. approval to a life sciences startup in London to use the psychedelic ingredient found in magic mushrooms in a trial for treating depression. The startup, Compass Pathways, was launched just two years ago with the backing of Peter Thiel. The trial is a phase IIB study of various dosages […]

03/25/2018 / By Frances Bloomfield

Magic mushrooms likely developed their psychedelic properties as a defense against predators

Psilocybin is the naturally occurring substance that puts the “magic” in “magic mushrooms.” Their psychedelic properties have made them popular for therapeutic, spiritual, and recreational use — for humans at least. But their biological purpose, as well as their evolutionary origins, has remained a mystery. Until now. A study, published in Evolution Letters, has suggested […]

06/08/2017 / By Bridgette Wilcox

Magic mushrooms are safest recreational drug, according to new study

Psilocybin mushrooms may be classified as a Schedule I drug alongside chemical substances such as MDMA, Heroin, LSD, and Methaqualone — but the substance is significantly less harmful than its classification indicates. According to the Global Drug Survey 2017, psilocybin mushrooms — known on the street as magic mushrooms or shrooms — is the safest of all recreational drugs, with […]

1 of 1